A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome)
Br J Dermatol
.
2022 Feb;186(2):215-226.
doi: 10.1111/bjd.20700.
Epub 2021 Nov 8.
Authors
B J A Verkouteren
1
2
,
B Cosgun
1
2
,
M G H C Reinders
1
2
,
P A W K Kessler
3
,
R J Vermeulen
4
,
M Klaassens
5
,
S Lambrechts
6
,
J R van Rheenen
7
,
M van Geel
1
2
8
,
M Vreeburg
8
,
K Mosterd
1
2
Affiliations
1
Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands.
2
GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
3
Department of Cranio-Maxillofacial Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
4
Department of Neurology, Maastricht University Medical Centre, Maastricht, the Netherlands.
5
Department of Paediatrics, Maastricht University Medical Centre, Maastricht, the Netherlands.
6
Department of Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands.
7
Department of Ophthalmology, St. Anna Hospital, Geldrop, the Netherlands.
8
Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.
PMID:
34375441
PMCID:
PMC9298899
DOI:
10.1111/bjd.20700
Abstract
Linked Comment:
E. Epstein. Br J Dermatol 2022; 186:203
.
Plain language summary
available online
MeSH terms
Basal Cell Nevus Syndrome* / therapy
Humans